Abstract
EMC virus has provided the most useful animal model for virus-induced type 1 diabetes. Development of diabetes depends on many factors including virus strain, challenge dose, host factors such as genetic background, sex, immunoprotective function, inflammatory responses with macrophages, cytokines, chemokines, and chemical mediators. Autoimmunity induction is not likely to be a factor in this model, though a hit-and-run event cannot be excluded. Most importantly, the difference between the diabetogenic strain D (EMC-D) and the non-diabetogenic strain B (EMC-B) virus depends on only one amino acid change due to single point mutation of “A” to “G” at position 3155 (Thr-776 to Ala-776), suggesting that possible acquisition of diabetogenicity may occur often among environmental “non-diabetogenic” viruses. Although susceptibility to the EMC-D virus-induced diabetes depends on the genetic background of mice, the genetic determinants of the host remain to be elucidated. Clarification of the pathogenesis of EMC virus-induced diabetes will not only promote a better understanding of the mechanisms of virus-induced diabetes in general, but will also contribute to the development of new protective strategies against viral diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bae YS, Eun HM, Yoon JW (1989) Genomic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 170:282–287
Bae Y, Yoon JW (1993) Determination of diabetogenicity attributable to a single amino acid Ala776, on the polyprotein of encephalomyocarditis virus. Diabetes 42:435–443
Baek HS, Yoon JW (1990) Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 64:5708–5715
Baek HS, Yoon JW (1991) Direct involvement of macrophages in destruction of β-cells leading to development of diabetes in virus-infected mice. Diabetes 40:1586–1597
Choi BK, Cho SH, Bai GH, Kim SJ, Hyun BH, Choe YK, Bae YS (2000) Prevention of encephalomyocarditis virus-induced diabetes by live recombinant mycobacterium bovis Bacillus Calmette-Guerin in susceptible mice. Diabetes 49:1459–1467
Chervonsky AV (2010) Influence of microbial environment on autoimmunity. Nat Immunol 11:28–33
Christen U, Hintermann E, Holdener M, von Herrath MG (2010) Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty? J Autoimmun 34:38–44
Clements GB, Galbraith DN, Taylor KW (1995) Coxsackie B virus infection and onset of child hood diabetes. Lancet 346:221–223
Craighead JE, McLane MF (1968) Diabetes mellitus induction in mice by encephalomyocarditis virus. Science 162:913–914
Devendra D, Eisenbarth GS (2004) Interferon alpha—a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 111:225–233
Eisenbarth GS, Gottlieb PA (2004) Autoimmune polyendocrine syndromes. N Engl J Med 350:2068–2079
Eun HM, Bae Y, Yoon JW (1988) Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 163:369–373
Fehsel AK, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H (1993) Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42:496–500
Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373–382
Hanafusa T, Imagawa A (2008) Insulitis in human type 1 diabetes. Ann NY Acad Sci 1150:297–299
Hirasawa K, Ogiso Y, Takeda M, Lee MJ, Itagaki S, Doi K (1995) Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice. Lab Anim Sci 45:652–656
Hirasawa K, Jun HS, Maeda K, Kawaguchi Y, Itagaki S, Mikami T, Baek HS, Doi K, Yoon JW (1997) Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 71:4024–4031
Hover D, Sauter P (2010) Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6:279–289
Huber SA, Babu PG, Craighead JE (1985) Genetic influences on the immunologic pathogenesis of encephalomyocarditis (EMC) virus-induced diabetes mellitus. Diabetes 34:1186–1190
Jenson AB, Rosenberg HS, Notkins AL (1980) Pancreatic islet-cell damage in children with fatal viral infections. Lancet 316:354–358
Jun HS, Kang Y, Notkins AL, Yoon JW (1997) Gain or loss of diabetogenicity result in from a single point mutation in recombinant encephalomyocarditis virus. J Virol 71:9782–9785
Jun HS, Kang Y, Yoon HS, Kim KH, Notkins AL, Yoon JW (1998) Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 47:576–582
Jun HS, Yoon JW (2001) The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 44:271–285
Kang Y, Yoon JW (1993) A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induce diabetes in mice. J Gen Virol 74:1207–1213
Kaptur PE, Thomas DC, Giron DJ (1989) The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus. J Interferon Res 9:671–678
Kawagishi A, Kubosaki A, Takeyama N, Sakudo A, Saeki K, Matsumoto Y, Hayashi T, Onodera T (2003) Analysis of T-cell receptor Vβ gene from infiltrating T cells in insulitis and myocarditis in encephalomyocarditis virus-infected BALB/C mice. Biochem Biophys Res Commun 310:791–795
Kogawa K, Kudoh J, Nagafuchi S, Ohga S, Katsuta H, Ishibashi H, Harada M, Hara T, Shimizu N (2002) Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associates with compound heterozygous novel AIRE gene mutations. Clin Immunol 103:277–283
Kounoue E, Nagafuchi S, Nakamura M, Nakano S, Koga T, Nakayama M, Mitsuyama M, Niho Y, Takaki R (1987) Encephalomyocarditis (EMC) virus-induced diabetes mellitus prevented by Corynebacterium parvum in mice. Experientia 43:430–431
Kounoue E, Izumi K, Ogawa S, Kondo S, Katsuta H, Akashi T, Niho Y, Harada M, Tamiya S, Kurisaki H, Nagafuchi S (2008) The significance of T cells, B cells, antibodies, and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice. Arch Virol 153:1223–1231
McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Calderon B, Gilfillan S, Diamond MS, Unanue ER, Colonna M (2011) RNA sensor-induced type 1 IFN prevents diabetes caused by a β-cell tropic virus in mice. J Clin Invest 121:1497–1507
Nagafuchi S, Katsuta H, Anzai K (2010) Rituximab, B-lymphocyte depletion, and beta-cell function. N Engl J Med 362:761
Nagamine K, Peterson P, Scott HD, Kudoh J, Minoshima S, Heino M, Krohn KJE, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECD gene. Nat Genet 17:393–398
Onodera AT, Yoon JW, Brown ES, Notkins AL (1978) Evidence for a single locus controlling susceptibility to virus-induced diabetes mellitus. Nature 274:693–696
Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, Raskin P, Rodriguez H, Schatz DA, Wherrett D, Wilson DM, Lachin JM, Skyler JS (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361:2143–2152
Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC (1994) DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37:733–738
Racaniello VR (2007) Picornaviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Straus SE, Martin MA, Roizman B (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 795–838
Richardson AJ, Willcox A, Bone AJ, Morgan N, Foulis AK (2011) Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33:9–21
Ross ME, Onodera T, Brown KS, Notkins AL (1975) Virus-induced diabetes mellitus. IV. Genetic and environmental factors influencing the development of diabetes after infection with the M variant of encephalomyocarditis virus. Diabetes 25:190–197
Sakaguchi S (2005) Naturally arising Foxp3-expressiong CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345–398
Santos CX, Anjos EI, Augusto O (1999) Uric acid oxidation by peroxynitrate: multiple reaction, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 372:285–294
Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger DB, Savage DA, Walker NM, Clayton DG, Todd JA (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38:617–619
Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol Rev 227:75–86
Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M, Shimura H, Takizawa S, Takahashi M, Akiyama D, Arai-Yamashita S, Furuya F, Kawaguchi A, Kaneshige M, Katoh R, Endo T, Kobayashi T (2009) Enterovirus infection CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit. Diabetes 58:2285–2291
Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H (2011) Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 33:45–55
Toniolo A, Onodear T, Yoon JW, Notkins AL (1980) Induction of cumulative environmental insults from viruses and chemicals. Nature 288:383–385
Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozocin and alloxan induced DNA strand breaks and poly ADP-ribose synthetase in pancreatic islets. Nature 294:284–286
Yoon JW, McLintock PR, Onodera T, Notkins AL (1980) Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocariditis virus. J Exp Med 152:878–892
Yoon JW, Rodrigues MM, Currier C, Notkins AL (1982) Long-term complications of virus-induced diabetes mellitus in mice. Nature 296:566–569
Yoon JW, McClintock PR, Bachurski CJ, Longstreth JD, Notkins AL (1985) Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of β-cell by the D-variant of encephalomyocarditis virus. Diabetes 34:922–923
Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signaling and immune regulation. Nat Rev Immunol 7:454–465
Acknowledgments
The authors thank Professor Takehiko Sasazuki for his helpful advice. We also thank Dr. Chiri Nagatsuka and Mrs Arisa Moroishi for their help in the preparation of the manuscript. Financial support by Ministry of Health, Labour and Welfare of Japan is acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nagafuchi, S., Kurisaki, H., Katsuta, H. (2013). Encephalomyocarditis Virus. In: Taylor, K., Hyöty, H., Toniolo, A., Zuckerman, A. (eds) Diabetes and Viruses. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4051-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4051-2_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4050-5
Online ISBN: 978-1-4614-4051-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)